Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2020

01-01-2020 | Mastectomy | Clinical trial

The Jacki Jacket after mastectomy with reconstruction: a randomized pilot study

Authors: Donna L. Berry, Traci M. Blonquist, Barbara Halpenny, Fangxin Hong, Samantha C. Morrison-Ma, Michele C. McCullough, Katherine Carelli, Laura S. Dominici, Tari A. King

Published in: Breast Cancer Research and Treatment | Issue 2/2020

Login to get access

Abstract

Background

Breast cancer patients undergoing mastectomy with reconstruction (TM + R) often experience post-operative discomfort from surgical drains. Despite a variety of garment options for use in the post-operative period, high-quality data assessing the impact of specific garments on post-operative pain are lacking. We report the results of a prospective randomized trial assessing the impact of the Jacki Jacket (JJ), a long-sleeve jacket with inner drain receptacle pockets, on post-discharge pain and quality of life (QOL) after TM + R.

Methods

Breast cancer patients undergoing TM + R at a single institution were randomized post-operatively to receive a JJ or usual care (UC). Participant-reported demographics, pain intensity, and QOL were collected on post-operative day 1 (T1). Following discharge, participants completed a daily pain and medication dairy (T2); on day of drain(s) removal (T3), participants again completed pain and QOL questionnaires. Linear models were used to evaluate associations between JJ use, post-operative pain, and QOL.

Results

From 3/8/17 to 12/20/17, 139 women were randomized. All participants completed T1 measures, 102 returned the T2 diary, and 118 (84.9%) completed T3 questionnaires. There was no significant difference in pain scores between JJ and UC arms at any timepoint. Adjusting for surgery type, age, marital status, depression, and obesity, participants randomized to JJ reported significantly better body image scores (estimate = 12.94, p = 0.009). There were no adverse events.

Conclusions

Although JJ garment use did not impact post-operative pain intensity scores, the significant impact of JJ use on body image supports consideration for inclusion of such garments in post-operative care for patients undergoing TM + R.

Clinical Trial Registration Information

Registered with ClinicalTrials.gov, NCT number NCT02976103, November 18, 2016.
Appendix
Available only for authorised users
Literature
1.
Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA (2015) Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg 150(1):9–16PubMedCrossRef
2.
Mamtani A, Morrow M (2016) Why are there so many mastectomies in the United States? Annu Rev Med 68:229–241PubMedCrossRef
3.
Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M (2017) Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer. Ann Surg 265(3):581–589PubMedCrossRef
4.
Cemal Y, Albornoz CR, Disa JJ, McCarthy CM, Mehrara BJ, Pusic AL, Cordeiro PG, Matros E (2013) A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg 131(3):320e–326ePubMedCrossRef
5.
Tuttle TM, Abbott A, Arrington A, Rueth N (2010) The increasing use of prophylactic mastectomy in the prevention of breast cancer. Curr Oncol Rep 12(1):16–21PubMedCrossRef
6.
Saratzis A, Soumian S, Willetts R, Rastall S, Stonelake PS (2009) Use of mulitple drains after mastectomy is associate with more patient discomfort and longer postoperative stay. Clin Breast Cancer 9(4):243–246PubMedCrossRef
7.
Brett P, Wang E, Mirrer J, Lanier S, Khan S, Dagum A, Bui DT (2014) Current practice among plastic surgeons of antibiotic prophylaxis and closed-suction drains in breast reconstruction: experience, evidence, and implications for postoperative care. Future Oncol 10(6):1049–1063CrossRef
8.
9.
Vadivelu N, Schreck M, Lopez J, Kodumudi G, Narayan D (2008) Invited commentary: pain after mastectomy and breast reconstruction. Am Surg 74(4):285–296PubMed
10.
Bruce J, Thornton AJ, Powell R, Johnston M, Wells M, Heys SD, Thompson AM, Cairns Smith W, Chambers WA, Scott NW et al (2014) Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a population-based cohort study. Pain 155(2):232–243PubMedCrossRef
11.
Poleshuck EL, Katz J, Andrus CH, Hogan LA, Jung BF, Kulick DI, Dworkin RH (2006) Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain 7(9):626–634PubMedPubMedCentralCrossRef
12.
Kudel I, Edwards RR, Kozachik S, Block BM, Agarwal S, Heinberg LJ, Haythornthwaite J, Raja SN (2007) Predictors and consequences of multiple persistent postmastectomy pains. J Pain Symptom Manag 34(6):619–627CrossRef
13.
Macdonald L, Bruce J, Scott NW, Smith WC, Chambers WA (2005) Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 92(2):225–230PubMedPubMedCentralCrossRef
14.
Schreiber KL, Martel MO, Shnol H, Shaffer JR, Greco C, Viray N, Taylor LN, McLaughlin M, Brufsky A, Ahrendt G et al (2013) Persistent pain in postmastectomy patients: comparison of psychophysical, medical, surgical, and psychosocial characteristics between patients with and without pain. Pain 154(5):660–668PubMedCrossRef
15.
Vos H, Smeets A, Neven P, Laenen A, Vandezande L, Nevelsteen I (2018) Early drain removal improves quality of life and clinical outcomes in patients with breast cancer—results from a randomised controlled trial. Eur J Oncol Nurs 36:112–118PubMedCrossRef
16.
McCorkle R, Cooley M, Shea J (2000) A User’s Manual for the Symptom Distress Scale. Yale University, New Haven
17.
PROMIS (2015) PAIN INTENSITY: a brief guide to the PROMIS Pain Intensity instrument. In: Patient reported outcomes measurement information system
18.
PROMIS (2015) PAIN INTERFERENCE: brief guide to the PROMIS Pain Interference instruments. In: Patient reported outcomes measurement information system
19.
Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) In: Group obotES (ed) EORTC QLQ-C30 scoring manual, 3rd edn. EORTC, Brussels
20.
Nguyen J, Popovic M, Chow E, Cella D, Beaumont JL, Chu D, DiGiovanni J, Lam H, Pulenzas N, Bottomley A (2015) EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review. J Comp Eff Res 4(2):157–166PubMedCrossRef
21.
Tobin J (1958) Estimation of relationships for limited dependent variables. Econometrica 26(1):24–36CrossRef
22.
23.
Team RC (2018) A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
24.
Temple-Oberle C, Shea-Budgell MA, Tan M, Semple JL, Schrag C, Barreto M, Blondeel P, Hamming J, Dayan J, Ljungqvist O et al (2017) Consensus review of optimal perioperative care in breast reconstruction: enhanced recovery after surgery (ERAS) Society recommendations. Plast Reconstr Surg 139(5):1056e–1071ePubMedCrossRefPubMedCentral
25.
Hah J, Mackey SC, Schmidt P, McCue R, Humphreys K, Trafton J, Efron B, Clay D, Sharifzadeh Y, Ruchelli G et al (2018) Effect of perioperative gabapentin on postoperative pain resolution and opioid cessation in a mixed surgical cohort: a randomized clinical trial. JAMA Surg 153(4):303–311PubMedCrossRef
26.
Syal K, Chandel A (2017) Comparison of the post-operative analgesic effect of paravertebral block, pectoral nerve block and local infiltration in patients undergoing modified radical mastectomy: a randomised double-blind trial. Indian J Anaesth 61(8):643–648PubMedPubMedCentralCrossRef
27.
Singh PM, Borle A, Kaur M, Trikha A, Sinha A (2018) Opioid-sparing effects of the thoracic interfascial plane blocks: a meta-analysis of randomized controlled trials. Saudi J Anaesth 12(1):103–111PubMedPubMedCentralCrossRef
28.
Zimmermann T, Scott JL, Heinrichs N (2010) Individual and dyadic predictors of body image in women with breast cancer. Psycho-oncology 19(10):1061–1068PubMedCrossRef
29.
Paterson CL, Lengacher CA, Donovan KA, Kip KE, Tofthagen CS (2016) Body image in younger breast cancer survivors: a systematic review. Cancer Nurs 39(1):E39–58PubMedPubMedCentral
30.
King MT, Kenny P, Shiell A, Hall J, Boyages J (2000) Quality of life three months and one year after first treatment for early stage breast cancer: influence of treatment and patient characteristics. Qual Life Res 9(7):789–800PubMedCrossRef
31.
Glassey R, Ives A, Saunders C, Musiello T (2016) Decision making, psychological wellbeing and psychosocial outcomes for high risk women who choose to undergo bilateral prophylactic mastectomy—a review of the literature. Breast 28:130–135PubMedCrossRef
32.
Rojas KE, Matthews N, Raker C, Clark MA, Onstad M, Stuckey A, Gass J (2018) Body mass index (BMI), postoperative appearance satisfaction, and sexual function in breast cancer survivorship. J Cancer Surviv 12(1):127–133PubMedCrossRef
33.
Weinberger NA, Kersting A, Riedel-Heller SG, Luck-Sikorski C (2016) Body dissatisfaction in individuals with obesity compared to normal-weight individuals: a systematic review and meta-analysis. Obes Facts 9(6):424–441PubMedPubMedCentralCrossRef
34.
Schreiber KL, Zinboonyahgoon N, Xu X, Spivey T, King T, Dominici L, Partridge A, Golshan M, Strichartz G, Edwards RR (2018) Preoperative psychosocial and psychophysical phenotypes as predictors of acute pain outcomes after breast surgery. J Pain 20(5):540–556PubMedCrossRefPubMedCentral
35.
Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR et al (2018) SEER cancer statistics review, 1975–2015. National Cancer Institute, Bethesda
36.
Jonczyk MM, Jean J, Graham R, Chatterjee A (2019) Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis. Breast Cancer Res Treat 173(2):267–274PubMedCrossRef
37.
A little easier recovery: Jacki patient feedback collection. 2015: 1–48
Metadata
Title
The Jacki Jacket after mastectomy with reconstruction: a randomized pilot study
Authors
Donna L. Berry
Traci M. Blonquist
Barbara Halpenny
Fangxin Hong
Samantha C. Morrison-Ma
Michele C. McCullough
Katherine Carelli
Laura S. Dominici
Tari A. King
Publication date
01-01-2020
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2020
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-019-05465-9

Other articles of this Issue 2/2020

Breast Cancer Research and Treatment 2/2020 Go to the issue

Preclinical study

Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment

Epidemiology

Patient-reported cosmetic satisfaction and the long-term association with quality of life in irradiated breast cancer patients

Clinical trial

Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies

Preclinical study

Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer

Editorial

Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction

Clinical Trial

Fulvestrant and palbociclib combination in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits